{"protocolSection": {"identificationModule": {"nctId": "NCT00046228", "orgStudyIdInfo": {"id": "CR005410"}, "secondaryIdInfos": [{"id": "FINESSE"}, {"id": "CR005410"}], "organization": {"fullName": "Centocor, Inc.", "class": "INDUSTRY"}, "briefTitle": "A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)", "officialTitle": "A Muticenter, Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy and Safety of Reteplease and Abciximab Combination Therapy With Abciximab Alone Administered Early or Just Prior to Primary Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction."}, "statusModule": {"statusVerifiedDate": "2014-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2002-08"}, "primaryCompletionDateStruct": {"date": "2008-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2002-09-24", "studyFirstSubmitQcDate": "2002-09-24", "studyFirstPostDateStruct": {"date": "2002-09-25", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-03-26", "resultsFirstSubmitQcDate": "2009-03-27", "resultsFirstPostDateStruct": {"date": "2009-05-15", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2014-07-25", "lastUpdatePostDateStruct": {"date": "2014-07-31", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Centocor, Inc.", "class": "INDUSTRY"}, "collaborators": [{"name": "Eli Lilly and Company", "class": "INDUSTRY"}]}, "descriptionModule": {"briefSummary": "The purpose of this study is to determine whether abciximab given in combination with reteplase, before patients have a coronary intervention (a standard treatment where a catheter is inserted into the heart artery to get blood flowing past the clot), is safe and effective in the treatment of heart attacks compared to only abciximab given during coronary intervention.", "detailedDescription": "The purpose of this medical research study is to determine whether abciximab given in combination with reteplase, before patients have a coronary intervention (a standard treatment where a catheter is inserted into the heart artery to get blood flowing past the clot), is safe and effective in the treatment of heart attacks compared to only abciximab given during coronary intervention. This medical research study will also help determine if the combination of abciximab and reduced dose reteplase will decrease the risk of death, and reduce complications of a heart attack at 90 days compared to abciximab alone which is a standard treatment.\n\nPatients will receive either abciximab and reteplease or abciximab alone. Safety evaluations will be performed at specified intervals throughout the study and will consist of laboratory tests, vital signs (such as blood pressure), physical examinations and the occurrence and severity of adverse events as well as other study specific procedures. Patients will receive either abciximab and reteplease or abciximab and placebo into a vein in their arm for up to 12 hours."}, "conditionsModule": {"conditions": ["Myocardial Infarction"], "keywords": ["Myocardial infarction", "percutaneous coronary intervention", "abciximab", "reteplase", "safety and efficacy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 2461, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "001", "type": "EXPERIMENTAL", "description": "Abciximab; reteplase; abciximab placebo; abciximab 0.25 mg/kg bolus; 1-2, 5 unit boluses; placebo bolus; 0.125 \u00bcg/kg/min, max 10 \u00bcg/min infusion x 12h", "interventionNames": ["Drug: abciximab placebo; reteplase placebo, abciximab, abciximab", "Drug: Abciximab; reteplase; abciximab placebo; abciximab"]}, {"label": "002", "type": "EXPERIMENTAL", "description": "abciximab; reteplase placebo; abciximab placebo; abciximab 0.25 mg/kg bolus; 1-2 placebo boluses; placebo bolus; 0.125 \u00bcg/kg/min, max 10 \u00bcg/min infusion x 12h", "interventionNames": ["Drug: Abciximab; reteplase; abciximab placebo; abciximab", "Drug: abciximab; reteplase placebo; abciximab placebo; abciximab"]}, {"label": "003", "type": "EXPERIMENTAL", "description": "abciximab placebo; reteplase placebo, abciximab, abciximab placebo bolus; 1-2 placebo bolus; 0.25 mg/kg bolus; 0.125 \u00bcg/kg/min, max 10 \u00bcg/min infusion x 12h", "interventionNames": ["Drug: abciximab; reteplase placebo; abciximab placebo; abciximab", "Drug: abciximab placebo; reteplase placebo, abciximab, abciximab"]}], "interventions": [{"type": "DRUG", "name": "abciximab placebo; reteplase placebo, abciximab, abciximab", "description": "placebo bolus; 1-2 placebo bolus; 0.25 mg/kg bolus; 0.125 \u00bcg/kg/min, max 10 \u00bcg/min infusion x 12h", "armGroupLabels": ["001"]}, {"type": "DRUG", "name": "Abciximab; reteplase; abciximab placebo; abciximab", "description": "0.25 mg/kg bolus; 1-2, 5 unit boluses; placebo bolus; 0.125 \u00bcg/kg/min, max 10 \u00bcg/min infusion x 12h", "armGroupLabels": ["002"]}, {"type": "DRUG", "name": "abciximab; reteplase placebo; abciximab placebo; abciximab", "description": "0.25 mg/kg bolus; 1-2 placebo boluses; placebo bolus; 0.125 \u00bcg/kg/min, max 10 \u00bcg/min infusion x 12h", "armGroupLabels": ["003"]}, {"type": "DRUG", "name": "abciximab placebo; reteplase placebo, abciximab, abciximab", "description": "placebo bolus; 1-2 placebo bolus; 0.25 mg/kg bolus; 0.125 \u00bfg/kg/min, max 10 \u00bfg/min infusion x 12h", "armGroupLabels": ["003"]}, {"type": "DRUG", "name": "abciximab; reteplase placebo; abciximab placebo; abciximab", "description": "0.25 mg/kg bolus; 1-2 placebo boluses; placebo bolus; 0.125 \u00bfg/kg/min, max 10 \u00bfg/min infusion x 12h", "armGroupLabels": ["002"]}, {"type": "DRUG", "name": "Abciximab; reteplase; abciximab placebo; abciximab", "description": "0.25 mg/kg bolus; 1-2, 5 unit boluses; placebo bolus; 0.125 \u00bfg/kg/min, max 10 \u00bfg/min infusion x 12h", "armGroupLabels": ["001"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "The Composite of All-Cause Mortality or Complications of MI at 90 Days.", "description": "Occurs within 90 days and is composite of all-cause mortality or complications of myocardial infarction (MI) (rehospitalization or emergency department visit for congestive heart failure (CHF), cardiogenic shock, or resuscitated ventricular fibrillation occurring \\> 48 hours after randomization).", "timeFrame": "90 days"}], "secondaryOutcomes": [{"measure": "Complications of MI as Defined in the Primary Outcome Measure Through 90 Days", "description": "The complications of myocardial infarction (MI) is defined as any event of rehospitalization or emergency department visit for CHF, cardiogenic shock, or resuscitated ventricular fibrillation occurring \\> 48 hours after randomization.", "timeFrame": "90 Days"}, {"measure": "All-Cause Mortality Through 90 Days", "description": "All cause mortality occurred through 90 days from randomization.", "timeFrame": "90 days"}, {"measure": "Subjects With ST-Segment Resolution > 70% From Baseline at 60 to 90 Minutes Following Randomization", "timeFrame": "60 to 90 minutes"}, {"measure": "All-Cause Mortality Through 1 Year", "description": "All-cause mortality through 1 year from randomization.", "timeFrame": "1 year"}], "otherOutcomes": [{"measure": "Subjects With Intracranial Hemorrhage (Including Hemorrhagic Transformation) Through Discharge/Day 7", "description": "All cases of cerebrovascular event were confirmed by a CEC (Clinical Endpoints Committee).", "timeFrame": "Discharge/Day 7"}, {"measure": "Subjects With Non Intracranial Thrombolysis In Myocardial Infarction (TIMI) Bleeding Events Through Discharge/Day 7", "description": "Subjects with nonintracranial TIMI bleeding (either major or minor) through discharge/day 7, originating from vascular instrumentation sites, non-instrument related bleeding, as well as overall, were examined.", "timeFrame": "Discharge/Day 7"}, {"measure": "Subjects With Severe Thrombocytopenia Through Discharge/Day 7", "description": "Severe thrombocytopenia is defined as platelet count \\< 50,000 cells/\u03bcL.", "timeFrame": "Discharge/Day 7"}, {"measure": "Subjects With Any Investigator Reported Bleeding Events Through Discharge/Day 7", "timeFrame": "Discharge/Day 7"}, {"measure": "Subjects With Pre-Specified Complications of Index Myocardial Infarction Through Discharge/Day 7", "description": "Number of subjects with one or more of the following: 2nd or 3rd Degree AVB, Asystole, Sustained V Tach, A Fib/Flutter, EMD/Pulseless Electrical Activity, Heart Failure, Tamponade, Myocardial Rupture, Papillary Muscle Rupture, Ventricular Septal Defect, Pulmonary Embolism, Systemic Arterial Embolism and/or Pericarditis/Pericardial Effusion.", "timeFrame": "Discharge/Day 7"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have prolonged, continuous (lasting at least 20 minutes) signs and symptoms of A heart attack not eliminated with nitrates and onset within 6 hours of randomization,and confirmation by Electrocardiogram\n\nExclusion Criteria:\n\n* Low risk clinical presentation\n* patients who will not be undergoing a catherization within 4 hours of the qualifying Electrocardiogram", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "21 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Centocor, Inc. Clinical Trial", "affiliation": "Centocor, Inc.", "role": "STUDY_DIRECTOR"}], "locations": [{"city": "Phoenix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"city": "Covina", "state": "California", "country": "United States", "geoPoint": {"lat": 34.09001, "lon": -117.89034}}, {"city": "Modesto", "state": "California", "country": "United States", "geoPoint": {"lat": 37.6391, "lon": -120.99688}}, {"city": "Newark", "state": "Delaware", "country": "United States", "geoPoint": {"lat": 39.68372, "lon": -75.74966}}, {"city": "Washington", "state": "District of Columbia", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}, {"city": "Clearwater", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.96585, "lon": -82.8001}}, {"city": "Jacksonville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"city": "Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"city": "Saint Petersburg", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}, {"city": "St Petersburg", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}, {"city": "Tallahassee", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.43826, "lon": -84.28073}}, {"city": "Weston", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.10037, "lon": -80.39977}}, {"city": "Harvey", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 41.61003, "lon": -87.64671}}, {"city": "Rock Island", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 41.50948, "lon": -90.57875}}, {"city": "Lexington", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"city": "Louisville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"city": "New Orleans", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"city": "Lewiston", "state": "Maine", "country": "United States", "geoPoint": {"lat": 44.10035, "lon": -70.21478}}, {"city": "Worcester", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.26259, "lon": -71.80229}}, {"city": "Ann Arbor", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"city": "Pontiac", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.63892, "lon": -83.29105}}, {"city": "Saint Louis", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"city": "Brooklyn", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.6501, "lon": -73.94958}}, {"city": "Flushing", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.76538, "lon": -73.81736}}, {"city": "Mineola", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.74927, "lon": -73.64068}}, {"city": "New York", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"city": "Raleigh", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"city": "Winston Salem", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"city": "Akron", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.08144, "lon": -81.51901}}, {"city": "Cleveland", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"city": "Dayton", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.75895, "lon": -84.19161}}, {"city": "Westlake", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.45532, "lon": -81.91792}}, {"city": "Oklahoma City", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"city": "Tulsa", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 36.15398, "lon": -95.99277}}, {"city": "Hershey", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.28592, "lon": -76.65025}}, {"city": "Philadelphia", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"city": "Sayre", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 41.97896, "lon": -76.5155}}, {"city": "Sellersville", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.35399, "lon": -75.3049}}, {"city": "Upland", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.85261, "lon": -75.38269}}, {"city": "Wormleysburg", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.26287, "lon": -76.91386}}, {"city": "York", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.9626, "lon": -76.72774}}, {"city": "Pawtucket", "state": "Rhode Island", "country": "United States", "geoPoint": {"lat": 41.87871, "lon": -71.38256}}, {"city": "Providence", "state": "Rhode Island", "country": "United States", "geoPoint": {"lat": 41.82399, "lon": -71.41283}}, {"city": "Spartanburg", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 34.94957, "lon": -81.93205}}, {"city": "Bristol", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.59511, "lon": -82.18874}}, {"city": "Kingsport", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.54843, "lon": -82.56182}}, {"city": "Amarillo", "state": "Texas", "country": "United States", "geoPoint": {"lat": 35.222, "lon": -101.8313}}, {"city": "Galveston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.30135, "lon": -94.7977}}, {"city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"city": "Lubbock", "state": "Texas", "country": "United States", "geoPoint": {"lat": 33.57786, "lon": -101.85517}}, {"city": "Bremerton", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.56732, "lon": -122.63264}}, {"city": "Marshfield", "state": "Wisconsin", "country": "United States", "geoPoint": {"lat": 44.66885, "lon": -90.1718}}, {"city": "Waukesha", "state": "Wisconsin", "country": "United States", "geoPoint": {"lat": 43.01168, "lon": -88.23148}}, {"city": "Adrogue", "country": "Argentina", "geoPoint": {"lat": -34.80041, "lon": -58.38384}}, {"city": "Buenos Aires", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"city": "Corrientes", "country": "Argentina", "geoPoint": {"lat": -27.4806, "lon": -58.8341}}, {"city": "Merlo", "country": "Argentina", "geoPoint": {"lat": -32.34288, "lon": -65.01396}}, {"city": "Rosario", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"city": "San Martin", "country": "Argentina", "geoPoint": {"lat": -33.08103, "lon": -68.46814}}, {"city": "Bruck An Der Mur", "country": "Austria", "geoPoint": {"lat": 47.41667, "lon": 15.28333}}, {"city": "Deutschlandsberg", "country": "Austria", "geoPoint": {"lat": 46.81528, "lon": 15.22222}}, {"city": "Innsbruck", "country": "Austria", "geoPoint": {"lat": 47.26266, "lon": 11.39454}}, {"city": "Linz", "country": "Austria", "geoPoint": {"lat": 48.30639, "lon": 14.28611}}, {"city": "Wien", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"city": "Antwerpen", "country": "Belgium", "geoPoint": {"lat": 51.21989, "lon": 4.40346}}, {"city": "Bonheiden", "country": "Belgium", "geoPoint": {"lat": 51.02261, "lon": 4.54714}}, {"city": "Eeklo", "country": "Belgium", "geoPoint": {"lat": 51.18703, "lon": 3.55654}}, {"city": "Gent", "country": "Belgium", "geoPoint": {"lat": 51.05, "lon": 3.71667}}, {"city": "Herentals", "country": "Belgium", "geoPoint": {"lat": 51.17655, "lon": 4.83248}}, {"city": "Mechelen", "country": "Belgium", "geoPoint": {"lat": 51.02574, "lon": 4.47762}}, {"city": "Reet", "country": "Belgium", "geoPoint": {"lat": 51.10201, "lon": 4.41264}}, {"city": "Turnhout", "country": "Belgium", "geoPoint": {"lat": 51.32254, "lon": 4.94471}}, {"city": "Waregem", "country": "Belgium", "geoPoint": {"lat": 50.88898, "lon": 3.42756}}, {"city": "Westmalle", "country": "Belgium", "geoPoint": {"lat": 51.29767, "lon": 4.69013}}, {"city": "Dimitrovgrad", "country": "Bulgaria", "geoPoint": {"lat": 42.05, "lon": 25.6}}, {"city": "Haskovo", "country": "Bulgaria", "geoPoint": {"lat": 41.93415, "lon": 25.55557}}, {"city": "Plovdiv", "country": "Bulgaria", "geoPoint": {"lat": 42.15, "lon": 24.75}}, {"city": "Sofia", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Edmonton", "state": "Alberta", "country": "Canada", "geoPoint": {"lat": 53.55014, "lon": -113.46871}}, {"city": "Montreal", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"city": "Repentigny", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.74222, "lon": -73.45008}}, {"city": "Benesov U Prahy", "country": "Czech Republic"}, {"city": "Bilovec N/A", "country": "Czech Republic"}, {"city": "Boskovice", "country": "Czech Republic", "geoPoint": {"lat": 49.48751, "lon": 16.65997}}, {"city": "Brno", "country": "Czech Republic", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"city": "Brunt\u00e1l 1", "country": "Czech Republic", "geoPoint": {"lat": 49.98844, "lon": 17.4647}}, {"city": "Brunt\u00e1l", "country": "Czech Republic", "geoPoint": {"lat": 49.98844, "lon": 17.4647}}, {"city": "Caslav N/A", "country": "Czech Republic"}, {"city": "Ceske Budejovice", "country": "Czech Republic", "geoPoint": {"lat": 48.97447, "lon": 14.47434}}, {"city": "Cesky Krumlov N/A", "country": "Czech Republic"}, {"city": "Hav\u00ed\u00f8ov 1", "country": "Czech Republic"}, {"city": "Hodon\u00edn 1", "country": "Czech Republic", "geoPoint": {"lat": 48.84893, "lon": 17.13244}}, {"city": "Hradec Kralove", "country": "Czech Republic", "geoPoint": {"lat": 50.20923, "lon": 15.83277}}, {"city": "Hranice 1", "country": "Czech Republic", "geoPoint": {"lat": 49.54796, "lon": 17.73469}}, {"city": "Jesen\u00edk 1", "country": "Czech Republic", "geoPoint": {"lat": 50.22937, "lon": 17.20464}}, {"city": "Jicin N/A", "country": "Czech Republic"}, {"city": "Jihlava N/A", "country": "Czech Republic"}, {"city": "Karniva-Ray N/A", "country": "Czech Republic"}, {"city": "Kyjov", "country": "Czech Republic", "geoPoint": {"lat": 49.01018, "lon": 17.12253}}, {"city": "Most N/A", "country": "Czech Republic"}, {"city": "Novy Jicin N/A", "country": "Czech Republic"}, {"city": "Odry", "country": "Czech Republic", "geoPoint": {"lat": 49.66255, "lon": 17.83084}}, {"city": "Olomouc", "country": "Czech Republic", "geoPoint": {"lat": 49.59552, "lon": 17.25175}}, {"city": "Ostrava", "country": "Czech Republic", "geoPoint": {"lat": 49.83465, "lon": 18.28204}}, {"city": "Pisek N/A", "country": "Czech Republic"}, {"city": "Poruba", "country": "Czech Republic"}, {"city": "Praha 10 N/A", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Praha 9", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Prerov N/A", "country": "Czech Republic"}, {"city": "Prostejov N/A", "country": "Czech Republic"}, {"city": "Strakonice N/A", "country": "Czech Republic"}, {"city": "Sumperk N/A", "country": "Czech Republic"}, {"city": "Svitavy N/A", "country": "Czech Republic"}, {"city": "Tabor N/A", "country": "Czech Republic"}, {"city": "Teplice", "country": "Czech Republic", "geoPoint": {"lat": 50.6404, "lon": 13.82451}}, {"city": "Trutnov N/A", "country": "Czech Republic"}, {"city": "T\u00f8eb\u00ed\u00e8 1", "country": "Czech Republic"}, {"city": "T\u00f8inec 1", "country": "Czech Republic"}, {"city": "Usti Nad Orlici N/A", "country": "Czech Republic"}, {"city": "Valasske Mezirici N/A", "country": "Czech Republic"}, {"city": "Vyskov N/A", "country": "Czech Republic"}, {"city": "Znojmo N/A", "country": "Czech Republic"}, {"city": "\u00dast\u00ed Nad Labem 11", "country": "Czech Republic", "geoPoint": {"lat": 50.6607, "lon": 14.03227}}, {"city": "Esbjerg N/A", "country": "Denmark"}, {"city": "Frederikshavn N/A", "country": "Denmark"}, {"city": "Hj\u00ffrring N/A", "country": "Denmark"}, {"city": "Horsens N/A", "country": "Denmark"}, {"city": "K\u00ffbenhavn Nv N/A", "country": "Denmark"}, {"city": "K\u00ffbenhavn Sud N/A", "country": "Denmark"}, {"city": "K\u00ffbenhavn \u0178", "country": "Denmark"}, {"city": "Odense N/A", "country": "Denmark"}, {"city": "Randers", "country": "Denmark", "geoPoint": {"lat": 56.4607, "lon": 10.03639}}, {"city": "Silkeborg", "country": "Denmark", "geoPoint": {"lat": 56.1697, "lon": 9.54508}}, {"city": "Viborg N/A", "country": "Denmark"}, {"city": "\u0178lborg", "country": "Denmark"}, {"city": "\u0178rhus N", "country": "Denmark"}, {"city": "Besancon Cedex", "country": "France", "geoPoint": {"lat": 47.24878, "lon": 6.01815}}, {"city": "Colmar N/A", "country": "France"}, {"city": "Metz", "country": "France", "geoPoint": {"lat": 49.11911, "lon": 6.17269}}, {"city": "Nancy Cedex N/A", "country": "France"}, {"city": "Nancy Cedex", "country": "France", "geoPoint": {"lat": 48.68439, "lon": 6.18496}}, {"city": "Nimes", "country": "France", "geoPoint": {"lat": 43.83333, "lon": 4.35}}, {"city": "Paris", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"city": "Vandoeuvre Les Nancy Cedex", "country": "France", "geoPoint": {"lat": 48.65, "lon": 6.18333}}, {"city": "Aachen", "country": "Germany", "geoPoint": {"lat": 50.77664, "lon": 6.08342}}, {"city": "Bad Nauheim", "country": "Germany", "geoPoint": {"lat": 50.36463, "lon": 8.73859}}, {"city": "Bad Segeberg", "country": "Germany", "geoPoint": {"lat": 53.94313, "lon": 10.30215}}, {"city": "Bremen", "country": "Germany", "geoPoint": {"lat": 53.07516, "lon": 8.80777}}, {"city": "Dresden", "country": "Germany", "geoPoint": {"lat": 51.05089, "lon": 13.73832}}, {"city": "Eschweiler", "country": "Germany", "geoPoint": {"lat": 50.81854, "lon": 6.27184}}, {"city": "Friedberg", "country": "Germany", "geoPoint": {"lat": 48.35693, "lon": 10.98461}}, {"city": "Fulda", "country": "Germany", "geoPoint": {"lat": 50.55162, "lon": 9.67518}}, {"city": "Hamburg", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"city": "Kaltenkirchen", "country": "Germany", "geoPoint": {"lat": 53.83292, "lon": 9.9581}}, {"city": "Magdeburg", "country": "Germany", "geoPoint": {"lat": 52.12773, "lon": 11.62916}}, {"city": "Mannheim", "country": "Germany", "geoPoint": {"lat": 49.4891, "lon": 8.46694}}, {"city": "Mei\u00dfen", "country": "Germany", "geoPoint": {"lat": 51.16158, "lon": 13.4737}}, {"city": "M\u00fcnchen", "country": "Germany", "geoPoint": {"lat": 48.13743, "lon": 11.57549}}, {"city": "M\u00fcnster", "country": "Germany", "geoPoint": {"lat": 51.96236, "lon": 7.62571}}, {"city": "Pfaffenhofen", "country": "Germany", "geoPoint": {"lat": 49.06444, "lon": 8.97639}}, {"city": "Radebeul", "country": "Germany", "geoPoint": {"lat": 51.10654, "lon": 13.66047}}, {"city": "Sch\u00f6nebeck", "country": "Germany", "geoPoint": {"lat": 52.01682, "lon": 11.7307}}, {"city": "Jerusalem", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"city": "Ramat-Gan", "country": "Israel", "geoPoint": {"lat": 32.08227, "lon": 34.81065}}, {"city": "Leeuwarden", "country": "Netherlands", "geoPoint": {"lat": 53.20139, "lon": 5.80859}}, {"city": "Bedzin", "country": "Poland", "geoPoint": {"lat": 50.32607, "lon": 19.12565}}, {"city": "Bielsko-Biala", "country": "Poland", "geoPoint": {"lat": 49.82245, "lon": 19.04686}}, {"city": "Boleslawiec", "country": "Poland", "geoPoint": {"lat": 51.26418, "lon": 15.5697}}, {"city": "Brzeg", "country": "Poland", "geoPoint": {"lat": 50.86079, "lon": 17.4674}}, {"city": "Czestochowa", "country": "Poland", "geoPoint": {"lat": 50.79646, "lon": 19.12409}}, {"city": "Gdansk N/A", "country": "Poland"}, {"city": "Gdynia Poland", "country": "Poland"}, {"city": "Gliwice N/A", "country": "Poland"}, {"city": "Gorlice", "country": "Poland", "geoPoint": {"lat": 49.65563, "lon": 21.16035}}, {"city": "Grojec", "country": "Poland", "geoPoint": {"lat": 51.86252, "lon": 20.86757}}, {"city": "Jastrzebie-Zdroj", "country": "Poland", "geoPoint": {"lat": 49.95542, "lon": 18.57479}}, {"city": "Katowice N/A", "country": "Poland"}, {"city": "Katowice", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"city": "Konin N/A", "country": "Poland"}, {"city": "Konskie N/A", "country": "Poland"}, {"city": "Koscierzyna", "country": "Poland", "geoPoint": {"lat": 54.12226, "lon": 17.98119}}, {"city": "Krakow N/A", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"city": "Lodz N/A", "country": "Poland"}, {"city": "Nowy Dwor M", "country": "Poland"}, {"city": "Nysa N/A", "country": "Poland"}, {"city": "Opole N/A", "country": "Poland"}, {"city": "Piotrkow Trybunalski", "country": "Poland", "geoPoint": {"lat": 51.40547, "lon": 19.70321}}, {"city": "Poznan N/A", "country": "Poland"}, {"city": "Radomsko", "country": "Poland", "geoPoint": {"lat": 51.06713, "lon": 19.44477}}, {"city": "Ruda Slaska", "country": "Poland", "geoPoint": {"lat": 50.2584, "lon": 18.85632}}, {"city": "Skierniewice", "country": "Poland", "geoPoint": {"lat": 51.95485, "lon": 20.15837}}, {"city": "Swidnica", "country": "Poland", "geoPoint": {"lat": 50.84378, "lon": 16.48859}}, {"city": "Tychy N/A", "country": "Poland"}, {"city": "Ustron N/A", "country": "Poland"}, {"city": "Warszawa N/A", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"city": "Warszawa Poland", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"city": "Warszawa", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"city": "Wroclaw", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"city": "Zabrze N/A", "country": "Poland"}, {"city": "Zyrardow N/A", "country": "Poland"}, {"city": "Bucuresti", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"city": "Cluj Napoca", "country": "Romania", "geoPoint": {"lat": 46.76667, "lon": 23.6}}, {"city": "Iasi", "country": "Romania", "geoPoint": {"lat": 47.16667, "lon": 27.6}}, {"city": "Targu Mures", "country": "Romania", "geoPoint": {"lat": 46.54245, "lon": 24.55747}}, {"city": "Arcadia Pretoria N/A", "country": "South Africa"}, {"city": "Cape Town Western Province", "country": "South Africa"}, {"city": "Roodepoort Central Gauteng", "country": "South Africa"}, {"city": "Alicante N/A", "country": "Spain"}, {"city": "Barcelona N/A", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Barcelona", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Madrid", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"city": "Santander N/A", "country": "Spain"}, {"city": "Santander", "country": "Spain", "geoPoint": {"lat": 43.46472, "lon": -3.80444}}, {"city": "Santiago De Compostela N/A", "country": "Spain"}, {"city": "Santiago De Compostela", "country": "Spain", "geoPoint": {"lat": 42.88052, "lon": -8.54569}}, {"city": "G\u00f6teborg N/A", "country": "Sweden"}, {"city": "G\u00f6teborg", "country": "Sweden", "geoPoint": {"lat": 57.70716, "lon": 11.96679}}, {"city": "Basel N/A", "country": "Switzerland"}, {"city": "Bruderholz N/A", "country": "Switzerland"}, {"city": "Liestal", "country": "Switzerland", "geoPoint": {"lat": 47.48455, "lon": 7.73446}}, {"city": "Antrim", "country": "United Kingdom", "geoPoint": {"lat": 54.7, "lon": -6.2}}, {"city": "Belfast", "country": "United Kingdom", "geoPoint": {"lat": 54.59682, "lon": -5.92541}}, {"city": "Brighton", "country": "United Kingdom", "geoPoint": {"lat": 50.82838, "lon": -0.13947}}, {"city": "Chichester", "country": "United Kingdom", "geoPoint": {"lat": 50.83673, "lon": -0.78003}}, {"city": "Durham", "country": "United Kingdom", "geoPoint": {"lat": 54.77676, "lon": -1.57566}}, {"city": "Glasgow", "country": "United Kingdom", "geoPoint": {"lat": 55.86515, "lon": -4.25763}}, {"city": "London", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"city": "Manchester", "country": "United Kingdom", "geoPoint": {"lat": 53.48095, "lon": -2.23743}}, {"city": "Middlesbrough N/A", "country": "United Kingdom", "geoPoint": {"lat": 54.57623, "lon": -1.23483}}, {"city": "Plymouth", "country": "United Kingdom", "geoPoint": {"lat": 50.37153, "lon": -4.14305}}, {"city": "Portadown", "country": "United Kingdom", "geoPoint": {"lat": 54.42302, "lon": -6.44434}}, {"city": "Southampton", "country": "United Kingdom", "geoPoint": {"lat": 50.90395, "lon": -1.40428}}, {"city": "St Leonards On Sea", "country": "United Kingdom", "geoPoint": {"lat": 50.85565, "lon": 0.5452}}, {"city": "Stockton On Tees", "country": "United Kingdom", "geoPoint": {"lat": 54.56848, "lon": -1.3187}}, {"city": "Worthing", "country": "United Kingdom", "geoPoint": {"lat": 50.81795, "lon": -0.37538}}]}, "referencesModule": {"references": [{"pmid": "15077099", "type": "RESULT", "citation": "Ellis SG, Armstrong P, Betriu A, Brodie B, Herrmann H, Montalescot G, Neumann FJ, Smith JJ, Topol E; Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events Investigators. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Am Heart J. 2004 Apr;147(4):E16. doi: 10.1016/j.ahj.2003.07.025."}, {"pmid": "18499565", "type": "RESULT", "citation": "Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008 May 22;358(21):2205-17. doi: 10.1056/NEJMoa0706816."}, {"pmid": "20170878", "type": "DERIVED", "citation": "Montalescot G, Ellis SG, de Belder MA, Janssens L, Katz O, Pluta W, Ecollan P, Tendera M, van Boven AJ, Widimsky P, Andersen HR, Betriu A, Armstrong P, Brodie BR, Herrmann HC, Neumann FJ, Effron MB, Lu J, Barnathan ES, Topol EJ; Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events Investigators. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv. 2010 Feb;3(2):203-12. doi: 10.1016/j.jcin.2009.11.012."}, {"pmid": "19850249", "type": "DERIVED", "citation": "Herrmann HC, Lu J, Brodie BR, Armstrong PW, Montalescot G, Betriu A, Neuman FJ, Effron MB, Barnathan ES, Topol EJ, Ellis SG; FINESSE Investigators. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. JACC Cardiovasc Interv. 2009 Oct;2(10):917-24. doi: 10.1016/j.jcin.2009.06.018."}, {"pmid": "19850248", "type": "DERIVED", "citation": "Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Hamankiewicz M, Pluta W, Oldroyd K, Ecollan P, Janssens L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators. 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. JACC Cardiovasc Interv. 2009 Oct;2(10):909-16. doi: 10.1016/j.jcin.2009.07.009."}], "seeAlsoLinks": [{"label": "A Study of Abciximab and Reteplase When Administered Prior to Catheterization After a Myocardial Infarction - Finesse", "url": "http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=15&filename=CR005410_CSR.pdf"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "A total of 2,461 subjects were enrolled in the study according to the sponsor's clinical trial management system. Out of 2461 subjects, 2,452 subjects were randomly assigned to the 3 treatment groups.", "recruitmentDetails": "The study was conducted in 20 countries. The FINESSE (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events) study began enrollment in August 2002. It was planned that approximately 3,000 subjects would be enrolled. Because of enrollment difficulty, subject enrollment was stopped on 30 Dec 2006.", "groups": [{"id": "FG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "FG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "FG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "periods": [{"title": "90 Days", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "806"}, {"groupId": "FG001", "numSubjects": "818"}, {"groupId": "FG002", "numSubjects": "828"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "The number completed includes subjects who died or were seen for a visit within specified window.", "numSubjects": "793"}, {"groupId": "FG001", "comment": "The number completed includes subjects who died or were seen for a visit within specified window.", "numSubjects": "810"}, {"groupId": "FG002", "comment": "The number completed includes subjects who died or were seen for a visit within specified window.", "numSubjects": "813"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "13"}, {"groupId": "FG001", "numSubjects": "8"}, {"groupId": "FG002", "numSubjects": "15"}]}]}, {"title": "1 Year", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "This is the number of participants that were originally randomized to the trial.", "numSubjects": "806"}, {"groupId": "FG001", "comment": "This is the number of participants that were originally randomized to the trial.", "numSubjects": "818"}, {"groupId": "FG002", "comment": "This is the number of participants that were originally randomized to the trial.", "numSubjects": "828"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "The number completed includes subjects who died or were seen for a visit within specified window.", "numSubjects": "787"}, {"groupId": "FG001", "comment": "The number completed includes subjects who died or were seen for a visit within specified window.", "numSubjects": "804"}, {"groupId": "FG002", "comment": "The number completed includes subjects who died or were seen for a visit within specified window", "numSubjects": "816"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "19"}, {"groupId": "FG001", "numSubjects": "14"}, {"groupId": "FG002", "numSubjects": "12"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "BG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "BG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "806"}, {"groupId": "BG001", "value": "818"}, {"groupId": "BG002", "value": "828"}, {"groupId": "BG003", "value": "2452"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "62.5", "spread": "11.4"}, {"groupId": "BG001", "value": "61.9", "spread": "11.8"}, {"groupId": "BG002", "value": "62.6", "spread": "11.4"}, {"groupId": "BG003", "value": "62.4", "spread": "11.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "207"}, {"groupId": "BG001", "value": "216"}, {"groupId": "BG002", "value": "219"}, {"groupId": "BG003", "value": "642"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "599"}, {"groupId": "BG001", "value": "602"}, {"groupId": "BG002", "value": "609"}, {"groupId": "BG003", "value": "1810"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "The Composite of All-Cause Mortality or Complications of MI at 90 Days.", "description": "Occurs within 90 days and is composite of all-cause mortality or complications of myocardial infarction (MI) (rehospitalization or emergency department visit for congestive heart failure (CHF), cardiogenic shock, or resuscitated ventricular fibrillation occurring \\> 48 hours after randomization).", "populationDescription": "Population is the intent-to-treat subjects. The intent-to-treat population is defined as all subjects randomly assigned to a treatment group and classified according to the randomization assignment.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "90 days", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "806"}, {"groupId": "OG001", "value": "818"}, {"groupId": "OG002", "value": "828"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "86"}, {"groupId": "OG002", "value": "81"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the primary PCI in terms of the primary efficacy outcome. Assuming the relative risk reduction for the reteplase/abciximab facilitated PCI group versus the Primary PCI group is 15% in lower risk, 25% in medium risk, and 35% in high risk, the power of this comparison (1,000 subjects per group) is 83.4 %.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.551", "pValueComment": "The null hypothesis was tested at the significance level of 0.049. If it is significant, the significance level of null hypotheses tested in the analyses 2 and 3 will be adjusted according to the modified Hochberg approach.", "statisticalMethod": "Log Rank", "statisticalComment": "Independent Clinical Endpoints Committee confirmed components of primary endpoint except for death \\& resuscitated v fib assessed by the investigator)", "paramType": "Hazard Ratio (HR)", "paramValue": "0.91", "ciPctValue": "95", "ciLowerLimit": "0.67", "ciUpperLimit": "1.23"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "The null hypothesis is if abciximab facilitated PCI is the same as the primary PCI in terms of the primary efficacy outcome. Assuming the relative risk reduction for the Abciximab facilitated PCI versus the Primary PCI group is 12.7%, in lower risk, 17.9% in medium risk, and 25.0% in high risk, the power of this comparison (1000 subjects per group) is 54.1%", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.858", "statisticalMethod": "Log Rank", "paramType": "Hazard Ratio (HR)", "paramValue": "0.97", "ciPctValue": "95", "ciLowerLimit": "0.72", "ciUpperLimit": "1.31"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the abciximab facilitated PCI in terms of the primary efficacy outcome. Assuming the relative risk reduction for the reteplase/abciximab facilitated PCI versus the abciximab facilitated PCI group is 2.6% in lower risk, 8.7% in medium risk, and 13.3% in high risk, the power of this comparison (1,000 subjects per group) is 13.5%.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.676", "statisticalMethod": "Log Rank", "paramType": "Hazard Ratio (HR)", "paramValue": "0.94", "ciPctValue": "95", "ciLowerLimit": "0.69", "ciUpperLimit": "1.27"}]}, {"type": "SECONDARY", "title": "Complications of MI as Defined in the Primary Outcome Measure Through 90 Days", "description": "The complications of myocardial infarction (MI) is defined as any event of rehospitalization or emergency department visit for CHF, cardiogenic shock, or resuscitated ventricular fibrillation occurring \\> 48 hours after randomization.", "populationDescription": "Population is the intent-to-treat subjects. The intent-to-treat population is defined as all subjects that have been randomly assigned to a treatment group and classified according to the randomization assignment.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "90 Days", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "806"}, {"groupId": "OG001", "value": "818"}, {"groupId": "OG002", "value": "828"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "72"}, {"groupId": "OG001", "value": "61"}, {"groupId": "OG002", "value": "61"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the primary PCI in complications of MI within 90 days.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.247", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.81", "ciPctValue": "95", "ciLowerLimit": "0.57", "ciUpperLimit": "1.16"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "The null hypothesis is if abciximab facilitated PCI is the same as the primary PCI in complications of MI within 90 days.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.278", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.82", "ciPctValue": "95", "ciLowerLimit": "0.58", "ciUpperLimit": "1.17"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the abciximab facilitated PCI in complications of MI within 90 days.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.944", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.99", "ciPctValue": "95", "ciLowerLimit": "0.68", "ciUpperLimit": "1.43"}]}, {"type": "SECONDARY", "title": "All-Cause Mortality Through 90 Days", "description": "All cause mortality occurred through 90 days from randomization.", "populationDescription": "Population is the intent-to-treat subjects. The intent-to-treat population is defined as all randomized subjects classified according to the randomization assignment.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "90 days", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "806"}, {"groupId": "OG001", "value": "818"}, {"groupId": "OG002", "value": "828"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "45"}, {"groupId": "OG002", "value": "43"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "The null hypothesis is if retaplase/abciximab facilitated PCI is the same as the primary PCI in 90-day all cause mortality.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.494", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "1.17", "ciPctValue": "95", "ciLowerLimit": "0.74", "ciUpperLimit": "1.84"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "The null hypothesis is if abciximab facilitated PCI is the same as the primary PCI in 90-day all cause mortality.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.338", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "1.25", "ciPctValue": "95", "ciLowerLimit": "0.79", "ciUpperLimit": "1.95"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "The null hypothesis is if retaplase/abciximab facilitated PCI is the same as the abciximab facilitated PCI in 90-day all cause mortality.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.781", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.94", "ciPctValue": "95", "ciLowerLimit": "0.61", "ciUpperLimit": "1.45"}]}, {"type": "SECONDARY", "title": "Subjects With ST-Segment Resolution > 70% From Baseline at 60 to 90 Minutes Following Randomization", "populationDescription": "Population is the intent-to-treat subjects who were selected for evaluation by electrocardiogram (ECG) core laboratory.Subjects, who were not evaluable for a 60-90 minute ECG, were considered not having a ST segment resolution.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "60 to 90 minutes", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "405"}, {"groupId": "OG001", "value": "432"}, {"groupId": "OG002", "value": "424"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "85"}, {"groupId": "OG002", "value": "108"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "The null hypothesis is if retaplase/abciximab facilitated PCI is the same as the primary PCI in ST-segment resolution \\>70% from baseline.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.016", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "1.50", "ciPctValue": "95", "ciLowerLimit": "1.08", "ciUpperLimit": "2.10"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "The null hypothesis is if abciximab facilitated PCI is the same as the primary PCI in ST-segment resolution \\>70% from baseline.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.670", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "1.08", "ciPctValue": "95", "ciLowerLimit": "0.76", "ciUpperLimit": "1.52"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "The null hypothesis is if retaplase/abciximab facilitated PCI is the same as the abciximab facilitated PCI in ST-segment resolution \\>70% from baseline.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.042", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "1.40", "ciPctValue": "95", "ciLowerLimit": "1.01", "ciUpperLimit": "1.93"}]}, {"type": "SECONDARY", "title": "All-Cause Mortality Through 1 Year", "description": "All-cause mortality through 1 year from randomization.", "populationDescription": "Population is the intent-to-treat subjects. The intent-to-treat population is defined as all randomized subjects classified according to the randomization assignment.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "1 year", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "806"}, {"groupId": "OG001", "value": "818"}, {"groupId": "OG002", "value": "828"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "60"}, {"groupId": "OG002", "value": "52"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.603", "statisticalMethod": "Log Rank", "paramType": "Hazard Ratio (HR)", "paramValue": "0.90", "ciPctValue": "95", "ciLowerLimit": "0.62", "ciUpperLimit": "1.32"}, {"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.765", "statisticalMethod": "Log Rank", "paramType": "Hazard Ratio (HR)", "paramValue": "1.06", "ciPctValue": "95", "ciLowerLimit": "0.73", "ciUpperLimit": "1.52"}, {"groupIds": ["OG001", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.415", "statisticalMethod": "Log Rank", "paramType": "Hazard Ratio (HR)", "paramValue": "0.86", "ciPctValue": "95", "ciLowerLimit": "0.59", "ciUpperLimit": "1.24"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subjects With Intracranial Hemorrhage (Including Hemorrhagic Transformation) Through Discharge/Day 7", "description": "All cases of cerebrovascular event were confirmed by a CEC (Clinical Endpoints Committee).", "populationDescription": "The population was defined as all subjects who were randomized and treated with any study agent, including those who discontinued for any reasons. Subjects randomized and treated was classified according to the study drug(s) received.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Discharge/Day 7", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "795"}, {"groupId": "OG001", "value": "805"}, {"groupId": "OG002", "value": "814"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "5"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the primary PCI in the risk of ICH.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.218", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "The null hypothesis is if abciximab facilitated PCI is the same as the primary PCI in the risk of ICH.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.497", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the abciximab facilitated PCI in the risk of ICH.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.062", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subjects With Non Intracranial Thrombolysis In Myocardial Infarction (TIMI) Bleeding Events Through Discharge/Day 7", "description": "Subjects with nonintracranial TIMI bleeding (either major or minor) through discharge/day 7, originating from vascular instrumentation sites, non-instrument related bleeding, as well as overall, were examined.", "populationDescription": "The population was defined as all subjects who were randomized and treated with any study agent, including those who discontinued for any reasons. Subjects randomized and treated was classified according to the study drug(s) received.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participant", "timeFrame": "Discharge/Day 7", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "795"}, {"groupId": "OG001", "value": "805"}, {"groupId": "OG002", "value": "814"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "81"}, {"groupId": "OG002", "value": "118"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the primary PCI in the risk of non-ICH TIMI bleeding events.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.001", "statisticalMethod": "Fisher Exact", "paramType": "Odds Ratio (OR)", "paramValue": "2.28", "ciPctValue": "95", "ciLowerLimit": "1.63", "ciUpperLimit": "3.19"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "The null hypothesis is if abciximab facilitated PCI is the same as the primary PCI in the risk of non-ICH TIMI bleeding events.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.025", "statisticalMethod": "Fisher Exact", "paramType": "Odds Ratio (OR)", "paramValue": "1.51", "ciPctValue": "95", "ciLowerLimit": "1.05", "ciUpperLimit": "2.15"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "The null hypothesis is if reteplase/abciximab facilitated PCI is the same as the abciximab facilitated PCI in the risk of non-ICH TIMI bleeding events.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.008", "statisticalMethod": "Fisher Exact", "paramType": "Odds Ratio (OR)", "paramValue": "1.52", "ciPctValue": "95", "ciLowerLimit": "1.12", "ciUpperLimit": "2.05"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subjects With Severe Thrombocytopenia Through Discharge/Day 7", "description": "Severe thrombocytopenia is defined as platelet count \\< 50,000 cells/\u03bcL.", "populationDescription": "The population was defined as all subjects who were randomized and treated with any study agent, including those who discontinued for any reasons. Subjects randomized and treated was classified according to the study drug(s) received.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Discharge/Day 7", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "795"}, {"groupId": "OG001", "value": "805"}, {"groupId": "OG002", "value": "814"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "16"}, {"groupId": "OG002", "value": "16"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.439", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}, {"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.438", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "1.000", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subjects With Any Investigator Reported Bleeding Events Through Discharge/Day 7", "populationDescription": "The population was defined as all subjects who were randomized and treated with any study agent, including those who discontinued for any reasons. Subjects randomized and treated was classified according to the study drug(s) received.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Discharge/Day 7", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "795"}, {"groupId": "OG001", "value": "805"}, {"groupId": "OG002", "value": "814"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "139"}, {"groupId": "OG001", "value": "178"}, {"groupId": "OG002", "value": "271"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.001", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}, {"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.020", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.001", "statisticalMethod": "Fisher Exact", "ciPctValue": "95"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Subjects With Pre-Specified Complications of Index Myocardial Infarction Through Discharge/Day 7", "description": "Number of subjects with one or more of the following: 2nd or 3rd Degree AVB, Asystole, Sustained V Tach, A Fib/Flutter, EMD/Pulseless Electrical Activity, Heart Failure, Tamponade, Myocardial Rupture, Papillary Muscle Rupture, Ventricular Septal Defect, Pulmonary Embolism, Systemic Arterial Embolism and/or Pericarditis/Pericardial Effusion.", "populationDescription": "Population is the intent-to-treat subjects. The intent-to-treat population is defined as all randomized subjects classified according to the randomization assignment.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Discharge/Day 7", "groups": [{"id": "OG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)"}, {"id": "OG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI"}, {"id": "OG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "806"}, {"groupId": "OG001", "value": "818"}, {"groupId": "OG002", "value": "828"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "128"}, {"groupId": "OG001", "value": "122"}, {"groupId": "OG002", "value": "120"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.434", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.90", "ciPctValue": "95", "ciLowerLimit": "0.69", "ciUpperLimit": "1.18"}, {"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.589", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.93", "ciPctValue": "95", "ciLowerLimit": "0.71", "ciUpperLimit": "1.22"}, {"groupIds": ["OG001", "OG002"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.809", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "0.97", "ciPctValue": "95", "ciLowerLimit": "0.74", "ciUpperLimit": "1.27"}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Primary PCI Group", "description": "Abciximab (bolus + 12 hr infusion) initiated just prior to primary percutaneous coronary intervention (PCI)", "seriousNumAffected": 159, "seriousNumAtRisk": 795, "otherNumAffected": 0, "otherNumAtRisk": 795}, {"id": "EG001", "title": "Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) administered as soon as possible after randomization, 12 hour infusion initiated prior to PCI", "seriousNumAffected": 182, "seriousNumAtRisk": 805, "otherNumAffected": 0, "otherNumAtRisk": 805}, {"id": "EG002", "title": "Reteplase/Abciximab Facilitated PCI Group", "description": "Abciximab (bolus) + reteplase (5 U + 5 U double bolus for subjects \\< 75 years of age; 5 U single bolus for subjects \u2265 75 years of age), abciximab 12 hour infusion initiated prior to PCI", "seriousNumAffected": 175, "seriousNumAtRisk": 814, "otherNumAffected": 0, "otherNumAtRisk": 814}], "seriousEvents": [{"term": "Coronary stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 23, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 38, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 27, "numAtRisk": 814}]}, {"term": "Shock cardiogenic", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 13, "numAtRisk": 814}]}, {"term": "Unstable angina", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 814}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 814}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 814}]}, {"term": "Congestive heart failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 814}]}, {"term": "Myocardial ischemia", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 814}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 814}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Left ventricular dysfunction", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Chronic congestive heart failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Heart disorder", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Myocardial rupture", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pericarditis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Spiral coronary artery dissection", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Stable angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Tricuspid insufficiency", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Anginal pain", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Aortic stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Coronary artery occlusion", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Coronary artery perforation", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Coronary in-stent restenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Coronary restenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Endocarditis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Left ventricular ejection fraction decreased", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Mitral insufficiency", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Mitral regurgitation", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Ventricular septal defect", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Fibrillation ventricular", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 26, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 21, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 16, "numAtRisk": 814}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 814}]}, {"term": "Tachycardia ventricular", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "AV block complete", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "AV block third degree", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Junctional bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Nonsustained ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Sinus bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Arrhythmia supraventricular", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Arrhythmia ventricular", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Asystolia", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Atrial fibrillation paroxysmal", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "AV block second degree", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Cardiac arrhythmia nos", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Cardiac rhythm disturbance", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Cardiopulmonary arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Electromechanical dissociation", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Intraventricular conduction defect", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Tachycardia atrial paroxysmal", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Ventricular bigeminy", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Ventricular febrillation paroxysm", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 814}]}, {"term": "Bronchopneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 814}]}, {"term": "Pulmonary edema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 814}]}, {"term": "Respiratory arrest", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Aspiration pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Breathing difficult", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Bronchitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Coughing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pleuritis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Respiratory disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Repiratory tract infection", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Respiratory tract lesion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Adult respiratory distress syndrome", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Breathlessness", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Dyspnea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Emphysema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Lower respiratory tract infection", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pleural exudate", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pneumonia interstitial", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Atherosclerosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 14, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 14, "numAtRisk": 814}]}, {"term": "Hypotension", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Syncope", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Blood pressure high", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hypertension", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Transient hypotension", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Collapse", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Hypertension arterial", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Hypovolemic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Septic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 19, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 12, "numAtRisk": 814}]}, {"term": "Death", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Non-anginal pain", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Non-ischemic chest pain", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Allergic reaction", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Allergic reaction to diagnostic agent", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Incarcerated abdonimal hernia", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Inguinal hernia", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Interstitial fluid increased", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Intolerance induced", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Malaise", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Musculoskeletal pain", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Nontoxic drug overdose", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pain", "organSystem": "General disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Diverticulitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Dysphagia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Esophageal reflux", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Ileus", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Intestinal Polyp", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Nontropical sprue", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pancreatitis acute", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Preploric ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Digestion impaired", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Duodenal ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Epigastric pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Esophagitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Gastric ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Gastroesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Intestinal obstruction", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Irritable bowel syndrome", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Stomach pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Stomach upset", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Acute renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 814}]}, {"term": "Urinary tract infection", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Chronic renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Creatinine increased", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Renal function decreased", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Urethral disorder nos", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Urinary retention", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Acute renal insufficiency", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Bladder stricture", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Nephritis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pyelonephritis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Renal insufficiency", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Hemorrhagic stroke", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Gastric hemorrhage", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "GI hemorrhage", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "GI hemorrhage - upper", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hemoptysis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hemorrhage nos", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hematemesis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Hemorrhage rectum", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Pulmonary hemorrhage", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Puncture site hematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Retroperitoneal hemorrhage (type unknown)", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Vomiting blood", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Stroke", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 814}]}, {"term": "Claudication intermittent", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Arterial stenosis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pseudoaneurysm", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Vasculitis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Cerebral infarction", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Cerebrovascular accident", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Claudication", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Extracardiact arterial aneurysm", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Peripheral ischemia", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Phlebitis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Transient ischemic attack", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pulmonary cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pulmonary carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Rectal adenocarcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Rectal carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Adenocarcinoma nos", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Breast carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Ovarian cyst malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Thrombosis coronary artery", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Thrombosis cardiac chamber", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Atheroembolism limb", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Embolism pulmonary", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Thrombophlebitis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Thrombosis venous deep", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Venous thrombosis leg", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Aseptic necrosis bone", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Bone fracture", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Myalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Skeletal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Synovitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Hypercholesterolemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Adult onset diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Hyponatremia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Fever", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Urosepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Wound healing impaired", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Wound infection", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Epilepsy grand mal", "organSystem": "Nervous system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Pre-syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Carpal tunnel syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Coma", "organSystem": "Nervous system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Gall bladder distention", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hepatobiliary dysfunction", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Jaundice", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Vasovagal reaction", "organSystem": "Nervous system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Thrombocytopenia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hemoglobin decreased", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Anemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Anemia microcytic", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Eruption", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Hyperthyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Delirium tremens", "organSystem": "Psychiatric disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Leukopenia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Coronary artery dissection", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Ventricular aneurysm", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Cardiac tamponade", "organSystem": "Cardiac disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Breath shortness", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Left ventricular thrombus", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 814}]}, {"term": "Phlebothrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 814}]}, {"term": "Anemia iron deficiency", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}, {"term": "Renal carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "WHOART", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 795}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 805}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 814}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Some AEs were collected separately per protocol and are reported as \"Other Pre-Specified Outcomes Measures\"."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "GT60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Executive Director Clinical Research", "organization": "Centocor Inc.", "email": "EBarnath@ITS.JNJ.COM", "phone": "1-800-972-9063", "phoneExt": "6171"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-07-01"}, "conditionBrowseModule": {"meshes": [{"id": "D000009203", "term": "Myocardial Infarction"}, {"id": "D000007238", "term": "Infarction"}], "ancestors": [{"id": "D000007511", "term": "Ischemia"}, {"id": "D000010335", "term": "Pathologic Processes"}, {"id": "D000009336", "term": "Necrosis"}, {"id": "D000017202", "term": "Myocardial Ischemia"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000014652", "term": "Vascular Diseases"}], "browseLeaves": [{"id": "M12155", "name": "Myocardial Infarction", "asFound": "Myocardial Infarction", "relevance": "HIGH"}, {"id": "M10282", "name": "Infarction", "asFound": "Infarction", "relevance": "HIGH"}, {"id": "M10543", "name": "Ischemia", "relevance": "LOW"}, {"id": "M12284", "name": "Necrosis", "relevance": "LOW"}, {"id": "M6546", "name": "Coronary Artery Disease", "relevance": "LOW"}, {"id": "M19506", "name": "Myocardial Ischemia", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000087896", "term": "Reteplase"}, {"id": "D000010959", "term": "Tissue Plasminogen Activator"}, {"id": "D000077284", "term": "Abciximab"}], "ancestors": [{"id": "D000000925", "term": "Anticoagulants"}, {"id": "D000010975", "term": "Platelet Aggregation Inhibitors"}, {"id": "D000005343", "term": "Fibrinolytic Agents"}, {"id": "D000050299", "term": "Fibrin Modulating Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M259825", "name": "Reteplase", "asFound": "Single-use vials", "relevance": "HIGH"}, {"id": "M1738", "name": "Abciximab", "asFound": "Blood sugar", "relevance": "HIGH"}, {"id": "M13848", "name": "Plasminogen", "relevance": "LOW"}, {"id": "M13849", "name": "Tissue Plasminogen Activator", "asFound": "Single-use vials", "relevance": "HIGH"}, {"id": "M4244", "name": "Anticoagulants", "relevance": "LOW"}, {"id": "M13865", "name": "Platelet Aggregation Inhibitors", "relevance": "LOW"}, {"id": "M8473", "name": "Fibrinolytic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "FiAg", "name": "Fibrinolytic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AnCoag", "name": "Anticoagulants"}, {"abbrev": "PlAggInh", "name": "Platelet Aggregation Inhibitors"}]}}, "hasResults": true}